Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Hans-Jürgen Thiesen
Tumour Fas Ligand:Fas Ratio Greater Than 1 Is an Independent Marker of Relative Resistance to Tamoxifen Therapy in Hormone Receptor Positive Breast Cancer
Breast Cancer Research
Cancer Research
Oncology
Related publications
Moesin Is an Independent Prognostic Marker for ER‑positive Breast Cancer
Oncology Letters
Cancer Research
Oncology
Nogo-B Receptor Increases the Resistance to Tamoxifen in Estrogen Receptor-Positive Breast Cancer Cells
Breast Cancer Research
Cancer Research
Oncology
Low P27 Expression Predicts Early Relapse and Death in Postmenopausal Hormone Receptor-Positive Breast Cancer Patients Receiving Adjuvant Tamoxifen Therapy
Clinical Cancer Research
Cancer Research
Oncology
Sphingosine Kinase 1 Activation by Estrogen Receptor Α36 Contributes to Tamoxifen Resistance in Breast Cancer
Journal of Lipid Research
Biochemistry
Endocrinology
Cell Biology
AKT1 - A New Marker for Tamoxifen Resistance in ER-Dependent Breast Cancer
The Aromatase Inhibitors as Adjuvant Therapy for Hormone Receptor-Positive Breast Cancer
Journal of the National Comprehensive Cancer Network : JNCCN
Medicine
Oncology
Mammographic Density Reduction Is a Prognostic Marker of Response to Adjuvant Tamoxifen Therapy in Postmenopausal Patients With Breast Cancer
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Progesterone Receptor Expression in Proliferating Cancer Cells of Hormone-Receptor-Positive Breast Cancer
Tumor Biology
Medicine
Cancer Research
Phosphorylation Independent eIF4E Translational Reprogramming of Selective mRNAs Determines Tamoxifen Resistance in Breast Cancer
Oncogene
Cancer Research
Genetics
Molecular Biology
